Pharmaceutical Intermediates Market to Incur High Value Growth at 4.4 % CAGR During 2019 - 2029 - PowerPoint PPT Presentation

About This Presentation

Pharmaceutical Intermediates Market to Incur High Value Growth at 4.4 % CAGR During 2019 - 2029


Global sales of pharmaceutical intermediates closed in on US$ 26 billion 2018, which is likely to see modest Y-o-Y growth in 2019, by an estimated 3.6% rate. More than 70% of the pharmaceutical intermediates consumed. – PowerPoint PPT presentation

Number of Views:149
Slides: 8
Provided by: Umesh213
Category: Other


Transcript and Presenter's Notes

Title: Pharmaceutical Intermediates Market to Incur High Value Growth at 4.4 % CAGR During 2019 - 2029

Pharmaceutical Intermediates Market to Incur High
Value Growth at 4.4 CAGR During 2019 - 2029
  • March 2020

Report Id REP-GB-4515 Published On 26 April,
2019 Category Healthcare, Pharmaceuticals
Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Pharmaceutical Intermediates Market
  • Global sales of pharmaceutical intermediates
    closed in on US 26 billion 2018, which is likely
    to see modest Y-o-Y growth in 2019, by an
    estimated 3.6 rate. More than 70 of
    the pharmaceutical intermediates consumed, were
    generic. A moderate demand growth outlook has
    been projected for branded pharmaceutical
  • Prominently driven by high sales of chiral
    intermediates, bulk drug intermediates will
    continue to account for over 3/5th of overall
    sales, followed by chemical intermediates. The
    report highlights pivotal role of CROs (contract
    research organizations) and CMOs (contract
    manufacturing organizations) in shaping the
    pharmaceutical intermediates market, as they
    collectively contribute more than 60 to the
    market value. Pharma and biotech companies are
    also likely to develop as key end users of
    pharmaceutical intermediates in the near future.
  • Application in Analgesics Account for a Third of
    Global Revenue
  • Increasing prevalence of the chronic diseases,
    coupled with the improved rate of early
    diagnosis, is heavily contributing to the
    towering drug demand. The report opines that
    prevalence rate of CVDs (cardiovascular diseases)
    and diabetes will particularly bolster
    pharmaceutical intermediates consumption. Over
    1/3rd of the pharmaceutical intermediates market
    revenues is accounted by application in
    analgesics, followed by cardiovascular drugs and
    oral antidiabetic drugs, as reported by the
  • Moreover, the increasing rate of seeking
    treatment is also likely to boost the demand for
    drugs. According to the report, global pandemics,
    such as H1N1, Ebola, and others are also
    accounting for fostering drug demand thereby
    pushing consumption of a wide range of APIs and
    pharmaceutical intermediates.

Pharmaceutical Intermediates Market
  • Manufacturing Companies to Strategize on
    Increasing Drug Approvals
  • A couple of years ago, the Center for drug
    evaluation and research (CDER) approved more than
    45 novel drugs, compared to 22 in 2016. The
    average novel drug approval each year, is around
    31 and, and thus FMIs analysis finds that the
    year 2017 witnessed a significant rise in the
    number of drug approvals. With the number of drug
    approvals on a constant rise, it is highly likely
    that the demand for pharmaceutical raw materials
    such as pharmaceutical intermediates and APIs
    will also witness gains in the years to come.
  • To cater to billowing demand in drug
    formulations, a number of players prominently
    active in the global pharmaceutical intermediates
    landscape are maintaining focus on expanding
    production capacity. Merck KGaA, for an instance,
    has announced production capacity expansion in
    Aubonne, Switzerland. The new production facility
    is supposed to be fully functional by the end of
    2023, as reported. The production capacity will
    be enhanced by over 50 of the existing.
  • Pharmaceutical intermediates manufacturers
    seeking cGMP (Current Good Manufacturing Practice
    regulations) approval from various western
    regulatory bodies. Key manufacturers of
    pharmaceutical intermediates, particularly those
    based in the East and South Asian regions, are
    focused on their efforts in gaining FDA or EMA
    (European Medicine Agency) regulatory approvals
    for their manufacturing plants.
  • FMIs research marks that the production costs
    associated with pharmaceutical intermediates,
    APIs, and final drug formulations is around
    50-60 less when based in emerging Asian markets,
    compared to that in North America and Europe.
    This cost benefit according to the report will
    continue to attract foreign investments from
    pharmaceutical and biopharmaceutical companies
    based in overseas. On the other side, leading
    exporters of pharmaceutical intermediates are
    focusing on blending the lower production costs
    and high quality.

Pharmaceutical Intermediates Market
  • The report tracks some of the key companies
    operating in the Pharmaceutical Intermediates
    market, including Chiracon GmbH, Aceto
    Corporation, Midas Pharma GmbH, BASF SE, Codexis,
    Inc., A.R. Life Sciences Private Limited, Dishman
    Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema
    Inc and Cambrex Corporation among others.
  • Source of Press-Release  https//www.globenewswir
  • About Us
  • Future Market Insights (FMI) is a leading market
    intelligence and consulting firm. We deliver
    syndicated research reports, custom research
    reports and consulting services which are
    personalized in nature. FMI delivers a complete
    packaged solution, which combines current market
    intelligence, statistical anecdotes, technology
    inputs, valuable growth insights and an aerial
    view of the competitive framework and future
    market trends.
  • Contact Us
  • Mr. Abhishek BudholiyaFuture Market Insights616
    Corporate Way, Suite 2-9018,Valley Cottage, NY
    10989,United StatesT 1-347-918-3531F
    1-845-579-5705T (UK) 44 (0) 20 7692

To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)